Midgard Science
AP

Amogen Pharma

Hyderabad, India amogenpharma.com From their website, Nov 2026

  • GLP
  • GMP

Work here? Claim this listing

About

Amogen Pharma develops and manufactures recombinant peptide and protein biosimilars for pharmaceutical partners. It operates from Hyderabad, India, with an office in Basel, Switzerland, and serves programs from early development through commercial supply.

Amogen Pharma is a CRDMO in Hyderabad, India, founded in 2020. It lists 12 services, including Microbial development services, Process development and Non-GMP/CGMP manufacturing. It names GLP and GMP on its listing.

Services

  • Microbial development services

    Genetic engineering, strain development, and microbial development in E. coli and yeast.

  • Process development

    Upstream and downstream process development from bench to commercial scale.

  • Non-GMP/CGMP manufacturing

    Flexible manufacturing from non-GMP toxicology through cGMP clinical and commercial supply.

    CDMO: development & manufacturing

  • Microbial manufacturing services

    Production of recombinant proteins and peptides with clinical and commercial supply capabilities.

    CDMO: development & manufacturing

  • Analytical development

    Comprehensive analytical method development, qualification, and transfer.

  • Microbial analytical services

    Bioassays, ELISA, microbiology, molecular biology, and related testing support.

  • Strain development

    Development of high-expressing, stable cell lines and strains.

  • Cell line development

    Proprietary platform processes for generating high-expressing, stable cell lines.

4 more services
  • Quality services
  • API supply
  • FDF licensing
  • Co-development
Lead time
NDA signed within 48 hours
What to send
  • Molecule information
  • Target markets
  • Development stage
  • Volume requirements
  • Analytical package review under NDA
Minimums and prices
Volume-linked pricing

How to order from Amogen Pharma

What to send, as they list it: Molecule information; Target markets; Development stage; Volume requirements; Analytical package review under NDA. Minimums and prices they state: Volume-linked pricing. Lead time they state: NDA signed within 48 hours. They take requests through the contact form on their website. You can contact them directly from this page, or request a quote through Midgard.

Capabilities

As they state on their website or in their listing.

Processes
  • Small molecule
  • Peptide
  • Recombinant protein
  • Biosimilar
  • E. coli expression
  • HPLC
6 more
  • Bioreactors
  • Process development
  • Analytical development
  • qPCR
  • ELISA
  • Toxicology
Capacity
  • 75,000 L total fermentation capacity
  • 100L pre-seed bioreactor x2
  • 1000L seed bioreactor x4
  • 10,000L production bioreactor x5
  • 4 x 10,000L trains
  • 15,000L production scale
3 more
  • 980 kg semaglutide API capacity annually
  • 980 kg GLP-1 fermentation output plant
  • 5 x 15KL production fermenters
Scales
Kilogram
Data supplied
LC-MS · HPLC

Equipment

  • UHPLC
  • HPLC-UV/PDA
  • LC-MS
  • HRMS
  • SEC-HPLC
  • qPCR
  • Preparative Chromatography

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GLPSelf-reported

  • GMPSelf-reported

    Scope: microbial production facility

Company

Type
CRDMO
Founded
2020
Team
75+ Scientific & Manufacturing Experts

Locations

Based in
Hyderabad, India
Sites
Basel, Switzerland
Serves
Global, India, UAE, Saudi Arabia, Qatar, Kuwait, Bahrain, Oman, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Canada

Public records

Parent company
AMOGEN PHARMA PRIVATE LIMITED · IN GLEIF

Similar labs